With professional service and various technology platforms at Creative Biolabs, we are dedicated to
providing exclusive B cell engineering service for anti-lymphoma antibody delivery to facilitate your project's
success.
Anti-Lymphoma Therapeutics
Lymphoma is a malignant tumor of the lymphatic system developed from immune system lymphocytes, with various forms and
obvious clinical manifestations. It is mainly divided into Hodgkin's lymphoma and non-Hodgkin's lymphoma. With the
rapid advances in research and treatment, there are several targeted antibody immunotherapy options for lymphoma.
Fig.1 Targeted antibody immunotherapy regimens for
Lymphoma. (Creative Biolabs)
B Cell Engineering Service for Anti-Lymphoma Antibody Delivery
Antibody-secreting B cells are long-lived cells that specialize in secreting proteins and are an attractive target for
foreign protein expression in blood and tissues. To speed up Lymphoma antibodies research, we are dedicated to
providing B cell engineering service for anti-lymphoma antibody delivery.
Fig.2 Flowchart of B Cell Engineering. (Creative Biolabs)
Engineering Primary B cells for Anti-Lymphoma Antibody Delivery
Primary B cells are attractive for genetic engineering to produce therapeutic proteins. These cells can
differentiate into plasma cells and long-lived memory cells, capable of producing robust and long-lasting antibodies
and migrating to lymphocytes, bone marrow, and vascular compartments. We provide both mouse and human primary B
cells for engineering, with effective primary cell stimulation strategies.
Several Efficient Genetic Methods Assisting B-cell Engineering for Anti-Lymphoma Antibody Delivery
Based on our scientists' years of experience, we offer several efficient genetic methods to enable customers to
achieve more precise genetic manipulation and optimize cell engineering and function. Here are some highly effective
genetic methods you can choose to use:
Several Hot Targets for Leukemia Research
Choosing the appropriate target is crucial to the smooth progress of the project. Based on years of experience, our
scientists will provide our clients with constructive suggestions for reference. There are a wide range of popular
targets you can choose to design for, including but not limited to:
CD19; CD20; CD22; CD30; CD37; CD38; CD70; CD74; CD79b; CD123; CD185; CD205; ROR1; HLA-DR;
Work with Creative Biolabs
Unlock in-depth insights with our B cell engineering service for anti-lymphoma antibody delivery
With cost-effective solutions and comprehensive quality control
With a clear and concise inquiry process
For more details about our B cell engineering service for anti-lymphoma antibody delivery, please don't hesitate to contact us for more information.
Fig.1 Targeted antibody immunotherapy regimens for
Lymphoma. (Creative Biolabs)
Fig.2 Flowchart of B Cell Engineering. (Creative Biolabs)
